Lucas W. Buchanan - 17 Jan 2023 Form 4 Insider Report for Silk Road Medical Inc

Role
COO/CFO
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
17 Jan 2023
Net transactions value
-$4,055,490
Form type
4
Filing time
19 Jan 2023, 19:01:10 UTC
Previous filing
15 Dec 2022
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $72,000 +45,000 +23% $1.60* 236,527 17 Jan 2023 Direct F1
transaction SILK Common Stock Sale $2,460,622 -45,000 -19% $54.68 191,527 17 Jan 2023 Direct F1, F2
transaction SILK Common Stock Options Exercise $20,426 +12,766 +6.7% $1.60* 204,293 19 Jan 2023 Direct F1
transaction SILK Common Stock Sale $681,736 -12,766 -6.2% $53.40 191,527 19 Jan 2023 Direct F1, F3
transaction SILK Common Stock Options Exercise $515,240 +25,762 +13% $20.00 217,289 19 Jan 2023 Direct F1
transaction SILK Common Stock Sale $1,375,755 -25,762 -12% $53.40 191,527 19 Jan 2023 Direct F1, F3
transaction SILK Common Stock Sale $145,041 -2,716 -1.4% $53.40 188,811 19 Jan 2023 Direct F3, F4
holding SILK Common Stock 13,518 17 Jan 2023 Buchanan Grandchildren's Irrevocable Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -45,000 -69% $0.000000 20,409 17 Jan 2023 Common Stock 45,000 $1.60 Direct F1, F6
transaction SILK Option (right to buy) Options Exercise $0 -12,766 -63% $0.000000 7,643 19 Jan 2023 Common Stock 12,766 $1.60 Direct F1, F6
transaction SILK Option (right to buy) Options Exercise $0 -25,762 -78% $0.000000 7,331 19 Jan 2023 Common Stock 25,762 $20.00 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on December 13, 2022.
F2 This transaction was executed in multiple trades at price ranging from $53.79 to $57.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at price ranging from $52.68 to $54.71. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on December 13, 2022.
F5 These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
F6 All of the shares subject to this option are fully vested and exercisable as of the date hereof.
F7 One forty-eighth of the shares subject to the option shall vest on May 3, 2019 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.